Written by
Recently, NHS England asked Trusts and Integrated Care Boards (ICBs) to confirm when in the next two years they would be adopting four analytics products, already available as part of the Federated Data Platform (FDP) being built by US data analytics giant Palantir.
The four products are: Referral to treatment validation (facilitating referral-to-treatment (RTT) pathway accuracy and progression); an inpatient care coordination solution (streamlining elective care with data insights to improve theatre use and support planning, improving data quality oversight and waiting list validation); an outpatient care coordination solution (enhancing clinic operations with waiting list validation), and discharge planning (OPTICA) (providing real-time tracking and task management for patient discharge processes).
When Palantir won the £330M ($436M), five-year contract late last year to build and implement a national data aggregation platform, there was no mention of …
